Clinical trial ENGOT-cx12 - SGNTV-003
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin versus Investigator's Choice Chemotherapy in Second or Third Line Recurrent or Metastatic Cervical Cancer
| Cancers | |
|---|---|
| Organ | Uterus |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 3 |
| Academic trial | Non |
| Sponsor | Seagen |
| EudraCT Identifier | 2019-001655-39 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04697628 |
| Last update |